Pembrolizumab vs Telmisartan
Pembrolizumab vs Telmisartan: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Telmisartan.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Telmisartan: Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
Pharmacokinetics
Half-life: Pembrolizumab β 26 days; Telmisartan β 24 hours.
Chemical Properties
Molecular Formula: Telmisartan β C33H30N4O2.
Molecular Weight: Telmisartan β 514.6230 g/mol.
Type: Pembrolizumab β Antibody; Telmisartan β Small molecule.